Related Experiment Video
Updated: Aug 16, 2026

Passive Administration of Monoclonal Antibodies Against H. capsulatum and Others Fungal Pathogens
Published on: February 14, 2011
Use of chloramphenicol in a hospice
Abstract:
Chloramphenicol has been the antibiotic of first choice at St Christopher's Hospice for over 20 years. Its use has been justified on the grounds of efficacy and tolerability in a patient group with a short prognosis in whom good symptom control is the priority. The sensitivities of hospice bacterial cultures to chloramphenicol and other antibiotics were recorded and were compared with the chloramphenicol sensitivities of cultures obtained from a series of hospital patients in the same area. Assessment of the occurrence of side effects attributed to chloramphenicol was made from hospice casenotes. Chloramphenicol was widely effective, but there was some evidence of the emergence of resistant strains, particularly of coliforms. Side effects were encountered less frequently than might have been expected from the use of popular alternative oral antibiotic drugs.
More Related Videos
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
07:28Metabolic Profiling to Determine Bactericidal or Bacteriostatic Effects of New Natural Products using Isothermal Microcalorimetry
Published on: October 29, 2020
Related Concept Videos
Continuing Care
Hand hygiene
Hand washing...
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Endocarditis IV: Nursing Management